These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30615569)

  • 21. Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic.
    Tolley EE; Zissette S; Taylor J; Hanif H; Ju S; Schwarz J; Thurman A; Tyner D; Brache V; Doncel GF
    J Womens Health (Larchmt); 2022 Sep; 31(9):1343-1352. PubMed ID: 35363574
    [No Abstract]   [Full Text] [Related]  

  • 22. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.
    Weinrib R; Minnis A; Agot K; Ahmed K; Owino F; Manenzhe K; Cheng H; van der Straten A
    AIDS Behav; 2018 Jan; 22(1):133-145. PubMed ID: 29052018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraceptive choice and acceptability: the future for STI risk in Kelantan, Malaysia.
    Shiely F; Saifuddin MS
    Int J STD AIDS; 2014 Mar; 25(3):219-27. PubMed ID: 23970646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies.
    Brady M; Tolley E
    BJOG; 2014 Oct; 121 Suppl 5():70-8. PubMed ID: 25335843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
    Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
    Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy.
    Dohadwala S; Geib MT; Politch JA; Anderson DJ
    Front Reprod Health; 2023; 5():1337479. PubMed ID: 38264184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perception of couples' on multipurpose prevention technology attribute choice: the case of MTN 045.
    Dandadzi A; Young AM; Musara P; Shapley-Quinn MK; Kemigisha D; Mutero P; Mgodi NM; Etima J; Minnis AA
    BMC Public Health; 2024 Jul; 24(1):1876. PubMed ID: 39004714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
    Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
    Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Who continues using the diaphragm and who doesn't: implications for the acceptability of female-controlled HIV prevention methods.
    Harvey SM; Bird ST; Maher JE; Beckman LJ
    Womens Health Issues; 2003; 13(5):185-93. PubMed ID: 14583167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.
    Boonstra H; Barot S; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():23-6. PubMed ID: 25335837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
    Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
    BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
    Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
    PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.
    Schurmans C; De Baetselier I; Kestelyn E; Jespers V; Delvaux T; Agaba SK; van Loen H; Menten J; van de Wijgert J; Crucitti T;
    BMC Public Health; 2015 Apr; 15():348. PubMed ID: 25880636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
    Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
    AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.
    Boulet SL; D'Angelo DV; Morrow B; Zapata L; Berry-Bibee E; Rivera M; Ellington S; Romero L; Lathrop E; Frey M; Williams T; Goldberg H; Warner L; Harrison L; Cox S; Pazol K; Barfield W; Jamieson DJ; Honein MA; Kroelinger CD
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):780-7. PubMed ID: 27490117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moving the Message Beyond the Methods: Toward Integration of Unintended Pregnancy and Sexually Transmitted Infection/HIV Prevention.
    Steiner RJ; Liddon N; Swartzendruber AL; Pazol K; Sales JM
    Am J Prev Med; 2018 Mar; 54(3):440-443. PubMed ID: 29287938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.